Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Stages II-III Breast Cancer
Interventions: DRUG: Nanoparticle Albumin Bound Paclitaxel|DRUG: doxorubicin|DRUG: cyclophosphamide
Sponsor: University of Utah
Collaborators: Celgene Corporation